Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 22.08
-0.32 (-1.43%)
Jun 18, 2026, 11:54 AM HKT
Medtide Market Cap
Medtide has a market cap or net worth of 3.18 billion as of June 17, 2026.
Market Cap
3.18B
Enterprise Value
2.01B
Revenue
634.40M
Ranking
n/a
PE Ratio
12.36
Stock Price
22.08
Market Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 3.18B, a decrease of -27.27%. That is a compound annual growth rate of -28.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 3.45B | -20.28% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 4.26B |
| Laekna | 3.74B |
| Guangzhou Innogen Pharmaceutical Group | 3.69B |
| Mirxes Holding Company | 3.66B |
| Jacobio Pharmaceuticals Group | 3.52B |
| Qyuns Therapeutics | 3.37B |
| Shandong Boan Biotechnology | 3.04B |
| Jiangsu Recbio Technology | 2.97B |